Condition (MeSH)
Hypokinesia
ClinicalTrials.gov lists 32 trials for Hypokinesia or a narrower condition beneath it. Great Lakes NeuroTechnologies Inc. has the most among industry and government lead sponsors, with 7.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
32 of the 32 trials are tagged with Hypokinesia itself; the rest are tagged with a narrower condition beneath it.
When did Hypokinesia trials start? (19)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 3 |
| 2024 | 2 |
| 2023 | 1 |
| 2020 | 1 |
| 2019 | 2 |
| 2016 | 1 |
| 2015 | 3 |
| 2014 | 1 |
| 2013 | 2 |
Showing 10 of 19 earlier years.
No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 29 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 18 months across 19 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hypokinesia trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 1/2 | 2 |
| Phase 4 | 1 |
| Not applicable | 16 |
| Observational | 11 |
How many Hypokinesia trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 3 |
| Enrolling by invitation | 4 |
| Completed | 22 |
| Terminated | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hypokinesia trials? (7)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Great Lakes NeuroTechnologies Inc. | 7 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| High Point Pharmaceuticals, LLC. | 1 |
| IMAC Holdings, Inc. | 1 |
| Mark Hallett | 1 |
Showing 5 of 7 sponsors.
Which drugs are being tested for Hypokinesia? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Mavodelpar | 1 |
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Standard Care | 1 |
| IR (Immediate-Release) quetiapine fumarate (drug) | 1 |
| Control (placebo) group | 1 |
| IR Risperidone | 1 |
| IM olanzapine | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Hypokinesia trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Confusion/Disorientation/Difficulty Concentrating/Distractability | 5 | 1 |
| Infection | 2 | 1 |
| Symptomatic Venous Hemorrhage | 2 | 1 |
| Transient Ischemic Attack | 2 | 1 |
| Air Embolus | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Hypokinesia? (98)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Validation of computer vision technology for analyzing bradykinesia in outpatient clinic videos of people with Parkinson's disease. | Journal of the neurological sciences | 2024 | Yes |
| Immobility-associated thromboprotection is conserved across mammalian species from bear to human. | Science (New York, N.Y.) | 2023 | Yes |
| Evolving concepts on bradykinesia. | Brain : a journal of neurology | 2020 | Yes |
| Is there evidence of bradykinesia in essential tremor? | European journal of neurology | 2020 | Yes |
| The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia? | Journal of the neurological sciences | 2020 | Yes |
Showing 5 of 98 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.